High-molecular weight HPMA copolymer-adriamycin conjugates

Area of Science:

• Polymer Chemistry
• Biomaterials Science
• Drug Delivery Systems

Background:

• N-(2-hydroxypropyl)methacrylamide (HPMA) copolymers are widely explored for drug delivery.
• Developing controlled release systems that respond to specific biological triggers remains a challenge.

Purpose of the Study:

• To synthesize novel branched, water-soluble HPMA copolymers with lysosomally degradable oligopeptide crosslinks.
• To incorporate a polymerizable anticancer drug, adriamycin (ADR), into these copolymer structures.
• To evaluate the enzymatic degradability of the crosslinks and the release of ADR.

Main Methods:

• Radical copolymerization of HPMA with custom-designed oligopeptide crosslinking agents.
• Control of polymer chain length using 3-mercaptopropionic acid.
• Synthesis of ADR-terminated HPMA copolymers.
• In vitro assessment of crosslink degradation and ADR release using isolated rat liver lysosomal enzymes.

Main Results:

• Successfully synthesized high-molecular weight, branched, water-soluble HPMA copolymers.
• Incorporated lysosomally degradable oligopeptide sequences into crosslinks and ADR into side-chains.
• Demonstrated enzymatic degradation of crosslinks and release of ADR by lysosomal enzymes.

Conclusions:

• The developed HPMA copolymers offer a promising platform for targeted drug delivery.
• The lysosomally degradable crosslinks facilitate controlled release of the conjugated anticancer drug.
• This approach holds potential for enhanced therapeutic efficacy and reduced systemic toxicity.